Rare condition

Kawasaki disease

ORPHA:2331 ↗

Search all Kawasaki disease trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

15 Apr 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Sponsor Duke UniversityWhere United States, Canada (52 sites)Studying The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:Updated 21 Aug 2026

See details

RecruitingPhase 4NCT05643651

Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease

Sponsor Children's Hospital of Fudan UniversityWhere China (1 site)Studying Rivaroxaban Oral Tablet [Xarelto], Aspirin or ClopidogrelUpdated 6 Jul 2026

See details

RecruitingPhase 3NCT07530640

Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities

Sponsor Children's Hospital of Fudan UniversityWhere China (1 site)Studying atorvastatin of dose level 1, atorvastatin of dose level 2Updated 16 Jun 2026

See details

RecruitingNot applicableNCT07291245

Kawasaki MATCH Trial

Sponsor University of California, San DiegoWhere United States (1 site)Studying Kawasaki MATCHUpdated 18 Dec 2025

See details

RecruitingNCT06305611

European and North Indian Cohort of KaWasaki dIsease

Sponsor Meyer Children's Hospital IRCCSWhere Brazil, Croatia, France +8 (27 sites)Updated 29 Sept 2025

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 11 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Brazil Canada China Croatia France India Israel Italy Netherlands Spain Thailand Turkey (Türkiye)United Kingdom United States

Keep watching

Get an email when a new Kawasaki disease study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:2331 ↗

About Kawasaki disease

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

1 approved treatment and 11 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Human Immunoglobulin G (Flebogamma dif (previously flebogammadif))

Phase 3Prednisolone (Cortalone)

Phase 3Aspirin (8-hour bayer)

Phase 3Anakinra (Antril)

Phase 3Polyethylene Glycol

Phase 3Infliximab (Flixabi)

Phase 2Defibrotide

Phase 2Pravastatin

Phase 2Canakinumab (Ilaris)

+ 3 more in development

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).